Skip to content

Effect of multi-mode preemptive analgesia on postoperative cognitive function and prognosis in elderly patients with hip fracture

Effect of multi-mode preemptive analgesia on postoperative cognitive function and prognosis in elderly patients with hip fracture

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096043
Enrollment
Unknown
Registered
2025-01-16
Start date
2025-01-27
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip fracture

Interventions

NSAIDs group:Pain management will performed with NSAIDs as demanded after admission
Bupivacaine liposome group (LB group):PENGB was performed with liposome bupivacaine
Bupivacaine hydrochloride group(BP group):PENGB was performed with bupivacaine hydrochloride

Sponsors

Yangpu District Central Hospital(Yangpu Hospital, School of Medicine, Tongji University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients aged 65 years and above who will undergo internal fixation of hip fracture in in Yangpu District Central Hospital of Shanghai . a. American Society of Anesthesiologists(ASA) grade ?~?; b. New York Heart Association (NYHA) Heart Function grades ? to?; c. Relevant auxiliary test has been perfected, including blood routine, liver and kidney function, coagulation, electrocardiogram, ultrasound, blood gas analysis, etc.; d. NRS>3 at rest e. Volunteer to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: a. Patients with mental system disease or cognitive dysfunction; b. Patients with sensory disorders such as hyperalgesia, or other physical pain that affects the evaluation of pain; c. Patients with a history of myocardial infarction or unstable angina pectoris within six months, or severe arrhythmias (such as atrioventricular block of degree II and above); d. Patients with diabetic peripheral neuropathy; e. Persons known to be allergic to bupivacaine or other amide local anesthetics; f. Contraindications to subarachnoid block and PENGB g. Long-term use of analgesics h. drug or alcohol abuse i. Patients who had any other factors deemed unsuitable for participation in the trial.

Design outcomes

Primary

MeasureTime frame
Incidence of cognitive dysfunction;

Secondary

MeasureTime frame
pain scores;Hemodynamic parameters need to be dealt with in perioperative period;The occurrence of deep vein thrombosis;Total analgesic medication;Muscle strength of lower limb;Complications or special events (e.g., hematoma, nerve injury, local anesthetic poisoning, etc.) within 48 hours from surgery to surgery;Total length of stay (days);Total hospital expenses;In-hospital mortality and all-cause mortality at 3 months after surgery;Incidence of postoperative chronic pain;C-reactive protein;Serum amyloid A;

Countries

China

Contacts

Public ContactYinglin Wang

Yangpu District Central Hospital(Yangpu Hospital, School of Medicine, Tongji University) ,

13907553360@163.com+86 189 1616 1593

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026